Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Down 5.1% in September

Aurora Cannabis Inc. (NASDAQ:ACB) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 2,590,000 shares, a drop of 5.1% from the September 15th total of 2,730,000 shares. Approximately 4.8% of the shares of the company are sold short. Based on an average daily volume of 1,280,000 shares, the days-to-cover ratio is currently 2.0 days.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in ACB. Virtu Financial LLC purchased a new position in Aurora Cannabis in the 1st quarter valued at about $727,000. TD Asset Management Inc acquired a new position in shares of Aurora Cannabis during the second quarter valued at approximately $255,000. Headlands Technologies LLC acquired a new position in shares of Aurora Cannabis during the first quarter valued at approximately $166,000. Mackenzie Financial Corp acquired a new position in shares of Aurora Cannabis during the second quarter valued at approximately $113,000. Finally, Concurrent Investment Advisors LLC acquired a new position in shares of Aurora Cannabis during the first quarter valued at approximately $90,000. 47.63% of the stock is owned by institutional investors and hedge funds.

Aurora Cannabis Stock Performance

ACB opened at $5.55 on Thursday. The firm has a fifty day moving average price of $5.93 and a 200 day moving average price of $6.06. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The stock has a market cap of $302.73 million, a P/E ratio of -3.96 and a beta of 1.86. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.76 and a quick ratio of 2.03.

Aurora Cannabis (NASDAQ:ACB) last posted its earnings results on Wednesday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.24. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. The business had revenue of $67.27 million for the quarter, compared to analyst estimates of $55.98 million. Equities research analysts anticipate that Aurora Cannabis will post -0.37 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.